Las hormonas esteroides y el páncreas: Un nuevo paradigma

Morales-Miranda, Angélica; Robles-Díaz, Guillermo; Díaz-Sánchez, Vicente.
Rev. invest. clín ; 59(2): 124-129, mar.-abr. 2007. ilus
Artigo Espanhol | LILACS | ID: lil-632366

Documentos relacionados

  1. Microenvironmental Determinants of Pancreatic Cancer.
  2. Early onset pancreatic cancer-exploring contemporary treatment and outcomes using real-world data.
  3. Hear Pancreatic Cancer Stem Cells ROR.
  4. Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data.
  5. Cancer surveillance awareness and practice among families at increased risk for pancreatic adenocarcinoma.
  6. Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma.
  7. Association of County-level Upward Economic Mobility with Stage at Diagnosis and Receipt of Treatment Among Patients Diagnosed with Pancreatic Adenocarcinoma.
  8. The prognostic significance of duodenal wall invasion in pancreatic adenocarcinoma.
  9. Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma.
  10. [Pre-malignant and malignant diseases of the pancreas, a centralized and multidisciplinary approach].